Login
Need to Register?   Forgot Password?


What's New?
  • FDA withdraws niacin & fibrate approvals in combination with statins
    Citing lack of cardiovascular benefit, the FDA is withdrawing approvals of niacin and fibrate combinations with statins
  • NLA cholesterol guidelines part 2
    Focus: lifestyle therapies and special populations
  • ESC2015 wrap-up & expert insights
    New PCSK9i data from ODYSSEY FH & ezetimibe favors diabetics in IMPROVE-IT
  • Are we SPRINTing toward lower BP targets? Not so fast, say the experts...
    Effect of intensive BP-lowering therapy in the SPRINT trial
  • Know Your Cholesterol [Infographic]
    Download this helpful infographic from the National Lipid Association
  • Cardiovascular Disease Education for HCPs
    CCMDweb.org provides CVD education for healthcare professionals spanning the continuum of cardiovascular and metabolic diseases. We focus on cardiometabolic conditions that individually or collectively contribute to cardiovascular risk, including dyslipidemia, atherosclerosis, type 2 diabetes, hypertension, stroke, inflammation,
    and obesity.

    Sign up to access:
    • Slide library with 1,000+ downloadable slides exploring cardiometabolic diseases
    • CVD guidelines resources
    • Case studies
    • Expert commentaries
    • Patient education handouts
    Click here for more information on CCMD.
    In the News
    FDA approves Adlyxin to treat type 2 diabetes
    Jul 29, 2016 -- The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2...

    Okra: Health Benefits and Nutritional Information
    Jul 29, 2016 -- Learn all about the health benefits and nutritional content of okra. As well as the benefits, this article offers some okra recipe suggestions.

    Copyright 2016 Medical News Today